Zenas BioPharma, Inc. Common Stock (ZBIO) financials · rev $10.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Zenas BioPharma, Inc. Common Stock (ZBIO) rev $10.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $10.0M | $5.00M |
| Operating Income | -$383.1M | -$163.9M |
| Net Income | -$377.7M | -$157.0M |
| EPS (Diluted) | -$8.44 | -$11.89 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $383.6M | $370.0M |
| Current Assets | $351.2M | $355.9M |
| Cash & Equivalents | $110.6M | $319.7M |
| PP&E | $34.0K | $185.0K |
| Total Liabilities | $141.5M | $57.5M |
| Current Liabilities | $62.6M | $57.3M |
| Long-term Debt | $78.6M | N/A |
| Total Debt | $78.6M† | N/A |
| Shareholders' Equity | $242.1M | $312.5M |
| Retained Earnings | -$765.1M | -$387.4M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$172.3M | -$119.7M |
| CapEx | $18.0K | $131.0K |
| Investing Cash Flow | -$251.9M | -$30.6M |
| Financing Cash Flow | $215.3M | $413.0M |
| Net Change in Cash | -$209.2M | $262.9M |
| Free Cash Flow | -$172.4M | -$119.8M |
FAQ
What is ZBIO P/E and revenue?
Zenas BioPharma, Inc. Common Stock (ZBIO) rev $10.0M.
What is ZBIO revenue?
Zenas BioPharma, Inc. Common Stock last cached revenue is $10.0M (FY2025).
Is ZBIO profitable?
Zenas BioPharma, Inc. Common Stock last cached net income is -$377.7M (FY2025).
What are ZBIO total assets?
Zenas BioPharma, Inc. Common Stock last cached total assets are $383.6M (FY2025).
What is ZBIO free cash flow?
Zenas BioPharma, Inc. Common Stock last cached free cash flow is -$172.4M (FY2025).
Not investment advice. Cached statements, not a live tape.